| 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial V Beckendorf, S Guerif, E Le Prisé, JM Cosset, A Bougnoux, B Chauvet, ... International Journal of Radiation Oncology* Biology* Physics 80 (4), 1056-1063, 2011 | 535 | 2011 |
| Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised … C Carrie, A Hasbini, G de Laroche, P Richaud, S Guerif, I Latorzeff, ... The Lancet Oncology 17 (6), 747-756, 2016 | 417 | 2016 |
| Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists P Giraud, S Elles, S Helfre, Y De Rycke, V Servois, MF Carette, C Alzieu, ... Radiotherapy and oncology 62 (1), 27-36, 2002 | 316 | 2002 |
| Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing P Giraud, Y De Rycke, B Dubray, S Helfre, D Voican, L Guo, ... International Journal of Radiation Oncology* Biology* Physics 51 (4), 1081-1092, 2001 | 230 | 2001 |
| Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. B Dubray, V Mosseri, F Brunin, C Jaulerry, P Poncet, J Rodriguez, ... Radiology 201 (2), 553-558, 1996 | 183 | 1996 |
| The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity V Beckendorf, S Guérif, E Le Prisé, JM Cosset, O Lefloch, B Chauvet, ... International Journal of Radiation Oncology* Biology* Physics 60 (4), 1056-1065, 2004 | 165 | 2004 |
| Can modest escalations of dose be detected as increased tumor control? HD Thames, TE Schultheiss, JH Hendry, SL Tucker, BM Dubray, ... International Journal of Radiation Oncology* Biology* Physics 22 (2), 241-246, 1992 | 162 | 1992 |
| Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and … P Vera, P Bohn, A Edet-Sanson, A Salles, S Hapdey, I Gardin, JF Ménard, ... Radiotherapy and Oncology 98 (1), 109-116, 2011 | 147 | 2011 |
| Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. A Denys, L Arrive, V Servois, B Dubray, D Najmark, A Sibert, Y Menu Radiology 193 (3), 665-669, 1994 | 121 | 1994 |
| Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival T Girinsky, R Lubin, JP Pignon, N Chavaudra, J Gazeau, B Dubray, ... International Journal of Radiation Oncology* Biology* Physics 25 (1), 3-7, 1993 | 118 | 1993 |
| Segmentation of Organs at Risk in thoracic CT images using a SharpMask architecture and Conditional Random Fields R Trullo, C Petitjean, S Ruan, B Dubray, D Nie, D Shen Biomedical Imaging (ISBI 2017), 2017 IEEE 14th International Symposium on …, 2017 | 106 | 2017 |
| In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas B Dubray, C Breton, J Delic, J Klijanienko, Z Maciorowski, P Vielh, ... Radiotherapy and oncology 46 (2), 185-191, 1998 | 101 | 1998 |
| Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation B Dubray, M Henry-Amar, JH Meerwaldt, EM Noordijk, DO Dixon, ... Radiotherapy and Oncology 36 (3), 211-217, 1995 | 99 | 1995 |
| Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations JM Cosset, G Socie, B Dubray, T Girinsky, A Fourquet, E Gluckman International Journal of Radiation Oncology* Biology* Physics 30 (2), 477-492, 1994 | 95 | 1994 |
| Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study). P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ... Journal of nuclear medicine: official publication, Society of Nuclear …, 2017 | 93 | 2017 |
| A qualitative and a quantitative analysis of an auto-segmentation module for prostate cancer DP Huyskens, P Maingon, L Vanuytsel, V Remouchamps, T Roques, ... Radiotherapy and Oncology 90 (3), 337-345, 2009 | 84 | 2009 |
| Robust feature selection to predict tumor treatment outcome H Mi, C Petitjean, B Dubray, P Vera, S Ruan Artificial intelligence in medicine 64 (3), 195-204, 2015 | 73 | 2015 |
| Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer J Calais, S Thureau, B Dubray, R Modzelewski, L Thiberville, I Gardin, ... J Nucl Med 56 (2), 196-203, 2015 | 72 | 2015 |
| Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study C Jaulerry, B Dubray, F Brunin, J Rodriguez, D Point, B Blaszka, ... International Journal of Radiation Oncology* Biology* Physics 33 (2), 271-279, 1995 | 72 | 1995 |
| Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC) A Edet-Sanson, B Dubray, K Doyeux, A Back, S Hapdey, R Modzelewski, ... Radiotherapy and Oncology 102 (2), 251-257, 2012 | 68 | 2012 |
Philippe GiraudProfesseur des Universités - Praticien Hospitalier Hôpital européen Georges Pompidou, Paris, FranceVerified email at aphp.fr
